Sign in

CIK 0002088082 · <br>Emerging growth company

Electra Therapeutics, Inc.

Sign in to watch
Ticker
ETRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
832193635
Phone
(888) 743-2290
Business address
230 EAST GRAND AVENUE, SUITE S-100, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$48,699,284
in 6 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$48,699,284. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. GORDON CARL L +$24.3M Director 3 filings
  2. ORBIMED ADVISORS LLC +$24.3M Director 3 filings
Date Insider Transaction Shares Price Value Owned after
2026-09-21 GORDON CARL L Director Conversion · Series C Convertible Preferred Stock −1,703,314 0
2026-09-21 GORDON CARL L Director Conversion · Series C Convertible Preferred Stock −758,279 0
2026-09-21 ORBIMED ADVISORS LLC Director Conversion +2,002,310 2,002,310
2026-09-21 ORBIMED ADVISORS LLC Director Conversion +1,087,934 3,090,244
2026-09-21 ORBIMED ADVISORS LLC Director Conversion +1,703,314 4,793,558
2026-09-21 ORBIMED ADVISORS LLC Director Purchase +333,333 $15.00 $5.0M 5,126,891
2026-09-21 ORBIMED ADVISORS LLC Director Conversion +758,279 758,279
2026-09-21 ORBIMED ADVISORS LLC Director Purchase +1,000,000 $15.00 $15.0M 1,758,279
2026-09-21 ORBIMED ADVISORS LLC Director Conversion · Series A Convertible Preferred Stock −2,002,310 0
2026-09-21 ORBIMED ADVISORS LLC Director Conversion · Series B Convertible Preferred Stock −1,087,934 0
2026-09-21 ORBIMED ADVISORS LLC Director Conversion · Series C Convertible Preferred Stock −1,703,314 0
2026-09-21 ORBIMED ADVISORS LLC Director Conversion · Series C Convertible Preferred Stock −758,279 0
2026-09-21 Parry Graham Chief Scientific Officer Conversion +85,504 85,504
2026-09-21 Parry Graham Chief Scientific Officer Conversion · Series A Convertible Preferred Stock −85,504 0
2026-09-21 Koe Gary S. Chief Technical Officer Conversion +63,656 63,656
2026-09-21 Koe Gary S. Chief Technical Officer Conversion · Series A Convertible Preferred Stock −63,656 0
2026-09-21 Dong Quehuong (Kathy) President & CEO Conversion +455,484 455,484
2026-09-21 Dong Quehuong (Kathy) President & CEO Conversion · Series A Convertible Preferred Stock −455,484 0
2026-09-21 Stagliano Nancy Director Conversion +255,635 255,635
2026-09-21 Stagliano Nancy Director Conversion · Series A Convertible Preferred Stock −255,635 0

Page 3 of 3 · 60 trades